ADCT — ADC Therapeutics SA Income Statement
0.000.00%
Last trade - 00:00- $131.91m
- $314.77m
- $70.84m
- 20
- 31
- 28
- 15
Annual income statement for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 10-K | 10-K | 10-K |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 33.9 | 210 | 69.6 | 70.8 |
| Cost of Revenue | |||||
| Gross Profit | — | 32.5 | 207 | 67 | 64.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 219 | 296 | 375 | 236 | 201 |
| Operating Profit | -219 | -262 | -165 | -166 | -131 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -246 | -252 | -147 | -195 | -156 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -246 | -230 | -147 | -235 | -156 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -246 | -230 | -157 | -240 | -158 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -246 | -230 | -157 | -240 | -158 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.21 | -3.07 | -1.66 | -2.94 | -1.62 |